| Date Filed | Type | Description |
| 02/12/2021 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Stemline Therapeutics, Inc. |
| 06/22/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 06/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/17/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/10/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 06/10/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 06/10/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 06/10/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 45,000 shares
@ $0
Unknown transaction of 327,878 shares
@ $0
Disposed/sold 45,102 options to buy
@ $4.12, valued at
$185.8k
|
|
| 06/10/2020 |
4
| Sard Mark (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 51,468 shares
@ $0 |
|
| 06/10/2020 |
4
| HUME DANIEL (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 35,468 shares
@ $0 |
|
| 06/10/2020 |
4
| Bergstein Ivan (CEO) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 220,000 shares
@ $0
Unknown transaction of 3,024,336 shares
@ $0
Disposed/sold 90,352 options to buy
@ $2.92, valued at
$263.8k
Disposed/sold 180,704 options to buy
@ $3.3, valued at
$596.3k
Disposed/sold 356,700 options to buy
@ $4.12, valued at
$1.5M
|
|
| 06/10/2020 |
4
| BENTSUR RON (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 66,346 shares
@ $0
Disposed/sold 9,034 options to buy
@ $2.92, valued at
$26.4k
Disposed/sold 18,070 options to buy
@ $3.3, valued at
$59.6k
Disposed/sold 34,000 options to buy
@ $6.78, valued at
$230.5k
Disposed/sold 24,000 options to buy
@ $8.2, valued at
$196.8k
|
|
| 06/10/2020 |
4
| Hoberman Kenneth (COO) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 600,000 shares
@ $0
Unknown transaction of 1,374,352 shares
@ $0
Disposed/sold 25,000 options to buy
@ $5.77, valued at
$144.3k
Disposed/sold 44,058 options to buy
@ $4.12, valued at
$181.5k
|
|
| 06/10/2020 |
4
| Francomano Robert (Chief Commercial Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 200,891 shares
@ $0
Disposed/sold 50,000 options to buy
@ $9.79, valued at
$489.5k
|
|
| 06/10/2020 |
4
| Cline Darren S (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 35,468 shares
@ $0 |
|
| 06/10/2020 |
4
| Forman Alan S (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 88,298 shares
@ $0
Disposed/sold 34,000 options to buy
@ $6.78, valued at
$230.5k
Disposed/sold 24,000 options to buy
@ $8.2, valued at
$196.8k
|
|
| 06/10/2020 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 60,121 shares
@ $0
Disposed/sold 34,000 options to buy
@ $6.78, valued at
$230.5k
Disposed/sold 24,000 options to buy
@ $8.2, valued at
$196.8k
|
|
| 06/10/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 06/10/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 06/10/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 06/10/2020 |
8-K
| Resignation/termination of a director |
| 06/04/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 06/02/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 06/02/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 06/01/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 05/27/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 05/21/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
|